Seeking Alpha

Acceleron Pharma beats by $0.14, beats on revenues

  • Acceleron Pharma (XLRN): Q1 EPS of -$0.30 beats by $0.14.
  • Revenue of $3.3M (-78% Y/Y) beats by $0.45M.
  • Press Release
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs